If you liked this article you might like

Novartis Passes FDA Blood Cancer Panel 'With Flying Colors,' Gives Positive Read Through For Others

Time to Take Profits in Bluebird Bio

Bluebird Bio Appoints Two New Directors to its Board

Thursday's 'Triathlon of Terror' Is Overblown: Cramer's 'Mad Money' Recap (Wednesday 6/7/17)

Bluebird Bio Stock Upgraded at BMO